Secor Capital Advisors’s NEVRO CORP. NVRO Stock Holding History

Secor Capital Advisors’s Portfolio NVRO Stock Details NVRO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-10,480	Closed	-$655K	–	279
2019 Q1	$655K	Buy	10,480 +1,291	+14%	+$60.7K	0.14%	226
2018 Q4	$357K	Sell	9,189 -76,530	-89%	-$3.4M	0.05%	350
2018 Q3	$4.89M	Buy	+85,719	New	+$5.36M	0.53%	44

Other funds holding NVRO

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

JSP

Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Secor Capital Advisors's NVRO Position: Q2 2019 in Review

Secor Capital Advisors sold out of NEVRO CORP. (NVRO) in Q2 2019, closing a stake of 10,480 shares — an estimated $655K sold.

Secor Capital Advisors first reported a position in NVRO in Q3 2018 and held it in 3 quarters. The position peaked at $4.89M in Q3 2018. 162 funds tracked by Wall St. Rank hold NVRO as of Q2 2019.

Secor Capital Advisors reported no remaining NEVRO CORP. position as of Q2 2019 after selling out during the quarter.
Secor Capital Advisors sold 10,480 NEVRO CORP. shares in Q2 2019, an estimated $655K.
Secor Capital Advisors first reported a position in NEVRO CORP. in Q3 2018 and held it in 3 quarters.
Secor Capital Advisors's NEVRO CORP. position peaked at $4.89M in Q3 2018.
162 funds tracked by Wall St. Rank held NEVRO CORP. as of Q2 2019.

Based on Secor Capital Advisors's 13F filing for Q2 2019.